In an amicus brief filed in Ortho Biotech Products v. United States ex rel. Mark Eugene Duxbury, the AHA said that if the First Circuit Court of Appeals’ decision were not reversed, it would undermine two key requirements for FCA actions:
- That private individuals attempting to bring lawsuits not trade on fraud allegations already disclosed to the public; and
- That they have specific knowledge of false or fraudulent claims before filing the case.
Read AHA News Now’s report on the False Claims Act.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
